Note: FanDuel is hosting a one-day Fantasy Baseball league tonight. It's $5 to enter and pays out $100,000 in cash prizes. First place wins $10,000. Sign up now!
Al Melchior already detailed what their promotions mean for Fantasy owners, as you'll see here and here. Long story short, Lindor isn't as much of priority as Buxton is since much of his upside comes from his defense. Granted, he wouldn't be the first prospect to figure it out at the major-league level, but his sub-.400 slugging percentage at Triple-A (not to mention poor efficiency on the base paths -- he was caught in nearly half of his stolen base attempts) doesn't inspire much confidence.
Of course, Buxton's Triple-A numbers -- he hit .283 with six home runs, a .840 OPS and 20 stolen bases in 237 at-bats -- may underwhelm you as well, relative to the hype, but I can't overstate how talented he is. Some publications ranked him ahead of even Kris Bryant coming into the season. Using minor-league production to project major-league performance isn't an exact science. Mike Trout wasn't a home run hitter even in some of the minors' most hitter-friendly leagues, and then suddenly he was in the majors. Sometimes the talent is so evident that the results are just noise, so if you're in one of the 16 percent of leagues where Buxton remains unowned, do something about it.
For all the attention Buxton and Lindor have gotten -- and continue to get, apparently -- they weren't the only notable callups from this weekend. One in particular has the potential to make just as big of an impact in Fantasy.
Rougned Odor, 2B, Rangers (24 percent owned)
Oh no, not him again.
Yes, Odor is back, only this time he may not stink so much. He developed some bad habits early this year -- specifically, expanding his strike zone -- that he quickly did away with at Triple-A Round Rock, batting .352 with five home runs and a 1.065 OPS in 108 at-bats. Most notably, he struck out only 10 times, which is much more befitting of his skill set.
The 21-year-old future 20-20 man (yes, I'm calling it) looked like he was coming into his own down the stretch last year, batting .290 with four home runs and an .836 OPS in his final 100 at-bats, so you shouldn't dismiss him because of some growing pains. Particularly if you play in a league that uses a middle infield spot, you could make room for him on your roster.
Jake McGee, RP, Rays (46 percent owned)
Will it be Brad Boxberger or will it be Kevin Jepsen? A week ago, that's what we were asking about the Rays' closer situation, and we've gotten some clarity since then. Given the way manager Kevin Cash has used his bullpen the last few days, I'm confident saying it'll be neither.
Jake McGee, who led the Rays in saves last year, handled three consecutive save opportunities (lefties, righties -- it didn't matter) with Boxberger pitching the eighth inning. Of course, then Boxberger blew a lead Saturday and wasn't used at all Sunday. With McGee also unavailable for that game, having worked three of the previous four, Jepsen ended up getting the save, which should cast enough doubt to make McGee still attainable for you.
Seems like a pretty straightforward case to me, though. McGee was supposed to be the guy before having surgery to remove a loose body from his elbow this offseason and has been lights out since his return in mid-May. If the role is his and his alone, he may be as dominant as Andrew Miller was in it.
Mat Latos, SP, Marlins (51 percent owned)
Wait a minute. We gave up on Latos in April, right?
Yes, we did -- and for good reason. He somehow managed to get by last season after elbow and knee surgery, compiling a 3.25 ERA in 16 starts, but he clearly wasn't the same, averaging a couple miles per hour less on his fastball with a greatly reduced strikeout rate.
Something seemed to click for him in his last start Saturday against the Rockies, though. He consistently hit 95-96 mph with his fastball, and it showed up in the results. He struck out 11 in seven innings, allowing just one earned run. He says he didn't feel right the first couple months after having fluid drained from his knee in spring training. I say that's as plausible of an excuse as any. Obviously, we don't know if it'll prove true over time, but increased velocity doesn't just happen.
Knowing how good Latos was before the surgery -- he ranked 16th among starting pitchers in 2013, compiling a 3.16 ERA, 1.21 WHIP and 8.0 strikeouts per nine innings -- I'm inclined to take a flier on him now.
Joe Ross, SP, Nationals (10 percent owned)
For as much help as everyone needs at starting pitcher -- the position has been shallower than expected this year -- the lack of interest in Ross astounds me.
In his second major-league start, he allows just two earned runs eight innings, striking out eight. That's a big deal. And it's not like he's some nobody. He was one of the key components in the three-team trade that sent Wil Myers to the Padres and Steven Souza to the Rays this offseason.
And he's the brother of Tyson Ross, who is most assuredly owned in your Fantasy league. He has his brother's ground-ball tendencies, inducing them at what would be the seventh-highest rate among starting pitchers if he had the innings to qualify, but he doesn't have his shaky control, issuing just one walk over 13 innings so far. The same was true at Double-A Harrisburg, where he issued 2.1 walks per nine innings prior to his promotion.
He has given up a fair number of hits in both the majors and minors, so in the long run, he may end up being another Charlie Morton. But the allure of the unknown draws me to Ross instead. Clearly, he has some tools to work with.